Evidence for involvement of α-adrenergic receptors in norepinephrine-induced prostaglandin E2 and luteinizing hormone-releasing hormone release from the median eminence

Sergio Ojeda, A. Negro-Vilar, S. M. McCann

Research output: Contribution to journalArticle

94 Scopus citations


Studies were conducted to determine if the stimulatory effect that norepinephrine (NE) exerts on the release of prostaglandin E2 (PGE2) and LHRH from the median eminence is mediated by α- or β-adrenergic receptors. Incubation of median eminence fragments from adult male rats with different concentrations of phentolamine, an α-receptor antagonist, resulted in a dose-related inhibition of the release of both PGE2 and LHRH induced by NE, with an IC50 of 3.5 x 10-7 and 0.9 x 10-7 M for PGE2 and LHRH, respectively. Complete suppression of the NE effects was observed with a phentolamine concentration of 5 x 10-6 M. This dose also reduced basal PGE2 and LHRH release. In contrast to phentolamine, the β-receptor antagonist propranolol, tested at a concentration of 5 x 10-6 M, was completely ineffective in altering the stimulatory effect of NE on either PGE2 or LHRH release. Moreover (and as previously observed for LHRH), blockade of dopaminergic receptors with Pimozide (10-6 M) failed to inhibit the release of PGE2 induced by NE, thus indicating that the stimulatory effect of NE is not mediated by a dopaminergic mechanism. It is concluded that NE stimulates the release of PGE2 and LHRH from nerve terminals of the median eminence by first interacting with an α-adrenergic receptor.

Original languageEnglish (US)
Pages (from-to)409-412
Number of pages4
Issue number2
Publication statusPublished - 1982
Externally publishedYes


ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this